Are Currently Available Biomarkers Useful to Discriminate CSU Patients Not Controlled by Low Dose Omalizumab Maintenance Therapy?

European Annals of Allergy and Clinical Immunology- Italy

doi 10.23822/eurannaci.1764-1489.139

Full Text

Abstract

Available in

Date

Authors

Publisher

Edra SpA

Related search

Omalizumab in Patients With Antihistamine-Resistant CSU

British Journal of Dermatology
DermatologyMedicine
2019English

Antinuclear Antibodies Are Common and Linked to Poor Response to Omalizumab Treatment in Patients With CSU

Allergy: European Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Clinical Effectiveness of Currently Available Low-Vision Devices in Glaucoma Patients With Moderate-To-Severe Vision Loss

Clinical Ophthalmology
Ophthalmology
2017English

Effects of Omalizumab on Chronic Urticaria Not Responding to Recommended Therapy

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2012English

Is Echocardiographic Assessment of Dyssynchrony Useful to Select Candidates for Cardiac Resynchronization Therapy?: Echocardiography Is Not Useful Before Cardiac Resynchronization Therapy if QRS Duration Is Available

Circulation. Cardiovascular imaging
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2008English

How to Meet Legitimate Expectations of Patients When Authorized Medicinal Products Are Not Available

Pharmaceutical Regulatory Affairs: Open Access
2012English

Low Dose Maintenance Medication for Schizophrenia

BMJ
1986English

Indacaterol Therapy in Patients With COPD Not Receiving Other Maintenance Treatment

Respiratory Medicine
PulmonaryRespiratory Medicine
2012English

Maintenance of Remission With Low-Dose Olopatadine Hydrochloride for Itch in Well-Controlled Chronic Urticaria

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy